Target intelligence / Profile preview

SLC60A2 pseudogene 1 (SLC60A2P1)

Target
SLC60A2P1
Molecular classification
Pseudogene, major facilitator superfamily (MFS) domain containing pseudogene, solute carrier (SLC) superfamily
01

Overview

SLC60A2 pseudogene 1 (SLC60A2P1, MFSD4BP1) is a human pseudogene classified in the solute carrier (SLC) superfamily, specifically identified as containing a major facilitator superfamily (MFS) domain. However, there is no current evidence supporting the existence of a functional protein encoded by this locus, and it is not considered a therapeutic target, transporter, receptor, enzyme, or other drug-binding protein. Pseudogenes like SLC60A2P1 can be remnants of genes that have lost their protein-coding potential through evolutionary mutations and typically lack biological activity or disease associations relevant for targeting. No evidence of biological function or disease association is reported for this pseudogene in current databases. Not a validated molecular target: Therapeutic targeting, drug interactions, and biomarker value have not been established. The major facilitator superfamily domain is found in many transporter proteins, but in the case of SLC60A2P1, this domain is present in a non-functional context due to its pseudogene nature. If you require information about the functional paralog (such as MFSD4B, which is a predicted sodium-dependent glucose transporter), please clarify, as SLC60A2P1 itself does not encode a functional molecule.

Other names
MFSD4BP1major facilitator superfamily domain containing 4B pseudogene 1

Beyond the preview

Go deeper on SLC60A2 pseudogene 1 (SLC60A2P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SLC60A2 pseudogene 1 (SLC60A2P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call